CCL2 and Patent ductus arteriosus: Furthermore, examination of CCL2 levels using IHC demonstrated overexpression in the primary tumor as well as in a metastatic lesion of human PDA (Figure 3B), where CCL2 was overexpressed starting in early disease and continued to be expressed highly throughout disease progression (Supplemental Figure 3A).